Ramelteon When Starting APAP: A Sleep-Onset Pilot

If falling asleep becomes difficult while you start an auto-adjusting positive airway pressure device, bring both concerns to the sleep team. Ask what the insomnia plan should achieve and how your breathing treatment will be reviewed.

What changed in the sleep laboratory?

The four-week pilot randomized 27 older adults; 21 were analyzed: eight taking ramelteon 8 mg and 13 taking placebo. Eight of those analyzed were women. Everyone started APAP.¹

The primary laboratory sleep-onset change favored ramelteon by 28.5 minutes (95% CI 8.5–48.6). This combined a 10.7-minute reduction with ramelteon and a 17.8-minute increase with placebo. It does not mean ramelteon shortened sleep onset by 28.5 minutes.¹

What remained uncertain?

Self-reported sleep onset, sleep quality and APAP adherence did not significantly differ. Sleep-study breathing measurements were taken while wearing APAP. Small, unequal groups, missing follow-up and four-week treatment limit interpretation. Takeda funded the pilot and supplied medication, with no role in design or interpretation reported.¹

Ask the clinician to distinguish three goals in your plan: falling asleep, feeling better the next day and using the prescribed device. At review, describe each separately. A note about when you remove the mask and what bothers you can give the team something specific to investigate.

Check the current prescription and breathing plan

The current US Rozerem label does not recommend use in severe sleep apnea. It also says its separate single-dose apnea study cannot definitively establish respiratory effects. Bring your sleep-study report to the prescriber; this pilot is not permission to use ramelteon with untreated apnea or to stop APAP.²

Ramelteon is labeled for insomnia involving difficulty falling asleep. Do not combine it with fluvoxamine or alcohol. The label warns against driving or hazardous activities after taking it and calls for reassessment if insomnia persists after 7–10 days. Tongue or throat swelling or difficulty breathing needs emergency care. Report activities such as sleep-driving promptly to the prescriber.²

NHLBI advises using prescribed PAP for all sleep, including naps, and contacting the provider about insomnia, mask leaks, claustrophobia or dryness. The team may address mask choice, humidification or pressure and timing settings.³

Bring your medicine list, the device name and a short account of the difficulty to the appointment. Request a review date and instructions for contacting the team between visits.

Did I Do That in My Sleep? includes “Medicines Belong in Shared Decisions,” covering expected benefit, interactions, next-day impairment, cost and a review plan.